ETPN management
After decision of the General Assembly 2017 in Torremolinos – Malaga (Spain), please find below the current composition of the ETPN Executive Board
Last updated: 30.10.2017
ETPN Bureau
Patrick Boisseau
ETPN Chairman
VP HealthTech at CEA Leti, France
Didier Letourneur
ETPN Vice-Chairperson
Director of Research – DR CNRS – INSERM U1148
Laurent Levy
ETPN Vice-Chairperson
CEO Nanobiotix, France
Philippe Mauberna
ETPN Treasurer
CFO at Nanobiotix
ETPN Working group leaders
Eusebio Gainza
W.G. Nanotherapeutics and targeted delivery
R&D Manager, BIOPRAXIS RESEARCH, Spain
Furio Gramatica
W.G. Clinical interface
Director, Development and Innovation at Fondazione Don Carlo Gnocchi
Olaf Rothaus
Chair of the Mirror Group
EuroNanoMed – Network Steering Commitee Chair, VDI Technologiezentrum GmbH, Germany
Paul Galvin
W.G. Medical devices
Head of ICT for Health Programmes at Tyndall National Institute
Adriele Prina-Mello
W.G. Education & Training
NANOMEDICINE PI at Trinity College Dublin, Ireland
Hans-Jörg Meisel
W.G. Regenerative Medicine
Director Center of Neurosciences, BG-Clinic Bergmannstrost Halle
Pedro Silva
W.G. Business Opporttunities
Technology Transfer Director at Instituto de Medicina Molecular, Lisbon
Klaus-Michael Weltring
A.G. Ethics & Social impact of Nanomedicine
Managing Director, Bioanalytik Muenster, Germany
Andreas Falk
W.G. Safety & characterization
CEO at BioNanoNet Forschungsgesellschaft mbH, Austria
ETPN Secretariat operational team
Alexandre Ceccaldi
ETPN General Secretary
Coordinator of the NOBEL Project
Alexandre Superville
Assistant manager of the NOBEL H2020 Project